CEO Interview
Nexien BioPharma, Inc (OTC: NXEN) Developing a cannabinoid-based drug pipeline.
Nexien BioPharma, Inc (OTC: NXEN) CEO Interview with Alex Wasyl discussing the company’s cannabinoid-based drug development pipeline. Drug development targets include, epliepsy, myotonia and other markets.